Pralidoxime - the gold standard of acetylcholinesterase reactivators - reactivation in vitro efficacy

Bratislava Medical Journal

Volumn 111, Issue 9, 2010, Pages 502-504

  Kuca, K ^a,b   Hrabinova, M ^a   Soukup, O ^b   Tobin, G ^c   Karasova, J ^b   Pohanka, M ^a  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cholinesterase; Inhibitor; Oxime; Pralidoxime; Reactivator

Indexed keywords

ACETYLCHOLINESTERASE; ANTIDOTE; CHOLINESTERASE REACTIVATOR; PRALIDOXIME;

ANIMAL; ARTICLE; BRAIN; IN VITRO STUDY; METABOLISM; RAT;

ACETYLCHOLINESTERASE; ANIMALS; ANTIDOTES; BRAIN; CHOLINESTERASE REACTIVATORS; PRALIDOXIME COMPOUNDS; RATS;

EID: 77957962647     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 2004; 38: 151-216.
2. Marrs TC. Organophosphate poisoning. Pharmacol Ther 1993; 58: 51-66.
3. Kuca K, Kassa J. In vitro reactivation of acetylcholinesterase using of the oxime K027. Vet Hum Toxicol 2004; 46: 15-18.
4. Li Y, Sun C, Qiu Z, Ma S, Yu X, Wang Z, Eddleston M. Clinical toxicology in China: current situation and future development. Clin Toxicol (Phila) 2009; 47: 263-269.
5. Eddleston M, Buckley NA, Eyer P, Dawson AH. Management of acute organophosphorus pesticide poisoning. Lancet 2008; 371: 597-607.
6. Kuca K, Cabal J, Jun D, Musilek K. In vitro reactivation potency of acetylcholinesterase reactivators - K074 and K075 - to reactivate tabun inhibited human brain cholinesterases. Neurotox Res 2007; 11: 101-106.
7. Wickramasinghe K, Steele P, Dawson A, Dharmaratne D, Gunawardena A, Senarathna L, de Siva D, Wijayaweera K, Eddleston M, Konradsen F. Cost to government health-care services of treating acute self-poisonings in a rural district in Sri Lanka. Bull World Health Organ 2009; 87: 180-185.
8. Musilek K, Jun D, Cabal J, Kassa J, Gunn-Moore F, Kuca K. Design of a potent reactivator of tabun-inhibited acetylcholinesterase - Synthesis and evaluation of (E)-l-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpy-ridinium)-but-2-ene dibromide (K203). J Med Chem 2007; 50: 5514-5518.
9. Kavalci C, Durukan P, Ozer M, Cevik Y, Kavalci G. Organophosphate poisoning due to a wheat bagel. Intern Med 2009; 48: 85-88.
10. Lundy PM, Raveh L, Amitai G. Development of the bisquaternaryoxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning. Toxicol Rev 2006; 25: 231-243.
11. Peter JV, Moran JL, Graham P. Oxime therapy and outcomes in human organophosphate poisoning: an evaluation using meta-analytic techniques. Crit Care Med 2006; 34: 502-510.
12. Petroianu GA, Hasan MY, Nurulain SM, Nagelkerke N, Kassa J, Kuca K. New K-oximes (K-27and K-48) in comparison with obidoxime (LuH-6), HI-6, trimedoxime (TMB-4) and pralidoxime (2-PAM): survival in rats exposed ip to the organophosphate paraoxon. Toxicol Mech Meth 2007; 17: 401-108.
13. Petroianu GA, Nurulain SM, Nagelkerke N, Shafiullah M, Kassa J, Kuca K. Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon. J Appl Toxicol 2007; 27: 453-457.
14. Lorke DE, Nurulain SM, Hasan MY, Kuca K, Musilek K, Petroianu GA. Eight new bispyridinium oximes in comparison with the con ventional oximes pralidoxime and obidoxime: In vivo efficacy to protect from diisopropylfluorophosphate (DFP) New toxicity. J Appl Toxi col 2008; 28: 920-928.
15. Musilek K., Lipka L., Racakova V., Kuca K., Jun D., Dohnal V., Dolezal V. methods in synthesis of acetylcholinesterase reactivators and evaluation of their potency to reactivate cyclosarin-inhibited AChE. Chemical Papers 2006; 60 (1): 48-51.
16. Jun D, Stodulka P, Kuca K, Koleckar V, Dolezal B, Simon P, Veverka M. HPLC analysis of HI-6 dichloride and dimethanesulfonate-antidotes against nerve agents and organophosphorus pesticides. Anal Lett 2007; 40: 2783-2787.
17. Jun D, Stodulka P, Kuca K, Koleckar V, Dolezal B, Simon P, Veverka M. TLC analysis of intermediates arising during the preparation of oxime HI-6 dimethanesulfonate. J Chrom Sci 2008; 46: 316-319.
18. Kuca K, Racakova V, Jun D. Relationship between structure of chlorpyrifos-inhibited acetylcholinesterase reactivators and their biological activity. Chem Pap 2007; 61: 256-261.
19. Novotny L, Karasova J, Kuca K, Bajgar J, Misik J. Influence of different wals of euthanasisa on the aktivity of cholinesterases in the rat. J Appl Biomed 2009; 7: (In Press).
20. Bartosova L, Kuca K, Kunesova G, Jun D. The acute toxicity of acetylcholinesterase reactivators in mice in relation to their structure. Neurotox Res 2006; 9: 291-296.
21. Pohanka M., Jun D., Kuca K. Amperometric biosensor for evaluation of competitive cholinesterase inhibition by the reactivator HI-6. Anal Lett 2007; 40: 2351-2359.
22. Kuca K, Kassa J. Oximes-induced reactivation of rat brain acetyl cholinesterase inhibited by VX agent. Hum Exp Toxicol. 2004; 23: 167-171.
23. Lorke DE, Hasan MY, Arafat K, Kuca K, Musilek K, Schmitt A, Petroianu GA. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate. J Appl To xicol 2008; 28: 422-429.
24. Lorke DE, Hasan MY, Nurulain SM, Sheen R, Kuca K, Petroianu GA. Entry of two new asymmetric bispyridinium oximes (K-27 and K-48) into the brain: comparison with obidoxime. J Applied Toxicol 2007; 27: 482-490.
25. Petroianu GA, Arafat K, Nurulain SM, Kuca K, Kassa J. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibitied by methyl-paraoxon. J Appl Toxicol 2007; 27: 168-175.
26. Lundy PM, Raveh L, Amitai G. Development of the bisquaternary oxime HI-6 toward clinical use in the treatment of organophosphate nerve agent poisoning. Toxicol Rev 2006; 25: 231-243.
27. Musilek K, Holas O, Kuca K, Jun D, Dohnal V, Dolezal M. Synthesis of the novel series of asymmetrical bispyridinium compounds bearing xylene linker and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase. J Enzyme Inhib Med Chem 2007; 22: 425-432.
28. Musilek K, Holas O, Kuca K, Jun D, Dohnal V, Opletalova V, Dolezal M. Synthesis of Monooxime-Monocarbamoyl Bispyridinium Compounds bearing (E)-but-2-ene Linker and Evaluation of their Reactivation Activity against Tabun- and Paraoxon-inhibited Acetylcholinesterase. J Enzyme Inhib Med Chem 2008; 23: 70-76.
29. Kuca K, Jun D, Bajgar J. Structural factors influencing potency of currently used acetylcholinesterase reactivators for treatment of cyclosarin intoxications. Curr Pharm Des 2007; 13: 3445-3452.
30. Kassa J, Jun D, Kuca K. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin and tabun-poisoned rats. J Enzyme Inhib Med Chem 2007; 22: 297-300.
31. Kassa J, Karasova J, Bajgar J, Kuca K, Musilek K. A comparison of the therapeutic and reactivating efficacy of newly developed bispyridinium compounds (K206, K269) with currently available oximes against tabun in rats and mice. J Enzyme Inhib Med Chem 2008; 23: 776-780.